PLASMA-PROTEIN BINDING DISPLACEMENT INTERACTIONS - WHY ARE THEY STILL REGARDED AS CLINICALLY IMPORTANT

被引:208
作者
ROLAN, PE
机构
[1] Department of Clinical Pharmacology, Wellcome Research Laboratories, Beckenham, Kent
关键词
D O I
10.1111/j.1365-2125.1994.tb04251.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:125 / 128
页数:4
相关论文
共 42 条
[1]   KINETICS OF DRUG DISPLACEMENT INTERACTIONS [J].
AARONS, LJ ;
ROWLAND, M .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (02) :181-190
[2]   POTENTIATION OF ANTICOAGULANT EFFECT OF WARFARIN BY PHENYLBUTAZONE [J].
AGGELER, PM ;
OREILLY, RA ;
LEONG, L ;
KOWITZ, PE .
NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (09) :496-&
[3]   PHENYLBUTAZONE-WARFARIN INTERACTION IN MAN - FURTHER STEREOCHEMICAL AND METABOLIC CONSIDERATIONS [J].
BANFIELD, C ;
OREILLY, R ;
CHAN, E ;
ROWLAND, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (06) :669-675
[4]  
BJORNSSON TD, 1979, J PHARMACOL EXP THER, V210, P316
[5]  
BJORNSSON TD, 1979, J PHARMACOL EXP THER, V210, P322
[6]   DISPLACEMENT OF 1 DRUG BY ANOTHER FROM CARRIER OR RECEPTOR SITES [J].
BRODIE, BB .
PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1965, 58 (11P2) :946-+
[7]  
CHRISTENSEN LK, 1963, LANCET, V2, P1298
[8]  
CLARK WG, 1988, GOTHS MED PHARM
[10]  
FOX SL, 1964, JAMA-J AM MED ASSOC, V188, P320